Net margin is calculated as Net Income divided by its Revenue. Cryo-Cell International's Net Income for the
three
months ended in Feb. 2024 was $0.56 Mil. Cryo-Cell International's Revenue for the
three
months ended in Feb. 2024 was $7.85 Mil. Therefore, Cryo-Cell International's net margin for the quarter that ended in Feb. 2024 was 7.08%.
The historical rank and industry rank for Cryo-Cell International's Net Margin % or its related term are showing as below:
CCEL'
s Net Margin % Range Over the Past 10 Years
Min: -31.02 Med: 7.21 Max: 38.43
Current: -31.02
CCEL's Net Margin % is ranked worse than 79.85% of 650
companies
in the Healthcare Providers & Services industry
Industry Median: 1.64
vs CCEL: -31.02
Cryo-Cell International Net Margin % Historical Data
The historical data trend for Cryo-Cell International's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cryo-Cell International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cryo-Cell International Net Margin % Distribution
For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Net Margin % distribution charts can be found below:
* The bar in red indicates where Cryo-Cell International's Net Margin % falls into.
Cryo-Cell International Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Cryo-Cell International's Net Margin for the fiscal year that ended in Nov. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cryo-Cell International (AMEX:CCEL) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Cryo-Cell International Net Margin % Related Terms
Thank you for viewing the detailed overview of Cryo-Cell International's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Cryo-Cell International (Cryo-Cell International) Business Description
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CCEL has been successfully added to your 